Makers Laboratories Ltd (MAKERSL) is currently trading at 192.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Makers Laboratories Limited is an Indian pharmaceuticals company focused on manufacture and sale of formulations and drug intermediates across tablets, liquids, injectables and ophthalmic products, with a consolidated structure that includes subsidiary Resonance Specialties Limited and manufacturing sites in Gujarat and Maharashtra. Consolidated performance shows meaningful scale and profitability: H1 FY2026 consolidated revenue expanded to Rs. 6,917.55 lakhs with positive operating cashflow of Rs. 312.45 lakhs, while standalone results show modest operational loss and negative operating cashflow, indicating Group-level strength driven by the subsidiary. The half year includes significant non-operating and one-off movements: standalone proceeds from sale of property, plant and equipment (Rs. 1,850.01 lakhs) and dividend/other income have materially affected cash and other income, so core operating profitability needs separation from these transitory items. Recent strategic moves include historical modernization of the Naroda injectable unit (completed January 2023) and the launch of new generic formulations and geographic expansion via new distributors in FY2026, which together suggest management is prioritizing capacity utilization and market expansion to drive volume-led growth.

Over the past 52 weeks, Makers Laboratories Ltd has traded between a low of ₹109.00 and a high of ₹239.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Makers Laboratories Ltd has a market capitalization of approximately 113.29. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Makers Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.16 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 113.29 Cr, Makers Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Makers Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Makers Laboratories Ltd is 33.16. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Consolidated revenue from operations was ₹42.77 crore and net profit attributable to owners was ₹1.50 crore for Q1FY27 (quarter ended June 30, 2026).

Consolidated net profit attributable to owners of the parent was ₹1.50 crore for Q1FY27 (quarter ended June 30, 2026), versus ₹0.44 crore in Q1FY26.